Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081470 | SCV000113401 | benign | not specified | 2013-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513085 | SCV001720621 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001513085 | SCV001871889 | benign | not provided | 2020-01-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807028 | SCV002054545 | benign | Developmental and epileptic encephalopathy, 62 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807027 | SCV002054546 | benign | Epilepsy, familial focal, with variable foci 4 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000081470 | SCV005087855 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 30. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001513085 | SCV005239576 | benign | not provided | criteria provided, single submitter | not provided |